NIVF
Price
$0.15
Change
-$0.04 (-21.05%)
Updated
Oct 22 closing price
Capitalization
359.96K
Intraday BUY SELL Signals
PIII
Price
$4.36
Change
+$0.25 (+6.08%)
Updated
Oct 22 closing price
Capitalization
17.06M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NIVF vs PIII

NIVF vs PIII Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NIVF vs. PIII commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NIVF is a StrongBuy and PIII is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NIVF with price predictions
Oct 22, 2026

NIVF in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 29, 2026

NIVF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 15 of 16 cases where NIVF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for NIVF just turned positive on October 02, 2026. Looking at past instances where NIVF's MACD turned positive, the stock continued to rise in 7 of 11 cases over the following month. The odds of a continued upward trend are 64%.

Following a +13.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where NIVF advanced for three days, in 67 of 80 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NIVF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for NIVF entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 16 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.014) is normal, around the industry mean (204.132). P/E Ratio (0.000) is within average values for comparable stocks, (18.957). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (0.005) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. NIVF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NIVF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

A.I.Advisor
a Summary for PIII with price predictions
Oct 22, 2026

PIII's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for PIII turned positive on October 22, 2026. Looking at past instances where PIII's MACD turned positive, the stock continued to rise in 30 of 35 cases over the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PIII's RSI Indicator exited the oversold zone, 32 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

Following a +9.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where PIII advanced for three days, in 197 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

PIII may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PIII declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for PIII entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.185) is normal, around the industry mean (204.132). P/E Ratio (-0.132) is within average values for comparable stocks, (18.957). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.100) among similar stocks. P/S Ratio (0.017) is also within normal values, averaging (2.688).

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. PIII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PIII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
NIVFPIII
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (NIVF: $0.19 vs. PIII: $4.11)
Brand notoriety: NIVF and PIII are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: NIVF: 65% vs. PIII: 79%
Market capitalization -- NIVF: $359.96K vs. PIII: $17.06M
NIVF [@Hospital/Nursing Management] is valued at $359.96K. PIII’s [@Hospital/Nursing Management] market capitalization is $17.06M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $99.46B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NIVF’s FA Score shows that 1 FA rating(s) are green while PIII’s FA Score has 1 green FA rating(s).

  • NIVF’s FA Score: 1 green, 4 red.
  • PIII’s FA Score: 1 green, 4 red.
According to our system of comparison, PIII is a better buy in the long-term than NIVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NIVF’s TA Score shows that 5 TA indicator(s) are bullish while PIII’s TA Score has 3 bullish TA indicator(s).

  • NIVF’s TA Score: 5 bullish, 2 bearish.
  • PIII’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, NIVF is a better buy in the short-term than PIII.

Price Growth

NIVF (@Hospital/Nursing Management) experienced а -35.81% price change this week, while PIII (@Hospital/Nursing Management) price change was -5.95% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.15%. For the same industry, the average monthly price growth was -3.02%, and the average quarterly price growth was +22.32%.

Reported Earning Dates

PIII is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Hospital/Nursing Management (+1.15% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
NIVF
Daily Signal:
Gain/Loss:
PIII
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

NIVF and

Correlation & Price change

A.I.dvisor tells us that NIVF and UHS have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NIVF and UHS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NIVF
1D Price
Change %
NIVF100%
-20.97%
UHS - NIVF
7%
Poorly correlated
+2.88%
ASTH - NIVF
7%
Poorly correlated
+1.77%
PIII - NIVF
6%
Poorly correlated
+6.08%
DVA - NIVF
4%
Poorly correlated
+5.25%
GRDN - NIVF
4%
Poorly correlated
+1.56%
More

PIII and

Correlation & Price change

A.I.dvisor tells us that PIII and ADUS have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PIII and ADUS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PIII
1D Price
Change %
PIII100%
+6.08%
ADUS - PIII
24%
Poorly correlated
+4.00%
SGRY - PIII
23%
Poorly correlated
+3.25%
ENSG - PIII
21%
Poorly correlated
+2.88%
OPCH - PIII
21%
Poorly correlated
N/A
HCSG - PIII
21%
Poorly correlated
+14.19%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RICK26.990.83
+3.17%
RCI Hospitality Holdings
TRST55.471.28
+2.36%
TrustCo Bank Corp
MOGU1.80-0.10
-5.49%
MOGU
P121.20-9.73
-7.43%
Everpure Inc
OII36.62-7.47
-16.94%
Oceaneering International